Brachytherapy
Volume 6, Issue 3 , Pages 207-211 , July 2007

Dose–volume characteristics of a 50-kV electronic brachytherapy source for intracavitary accelerated partial breast irradiation

  • Melanie C. Smitt

      Affiliations

    • Department of Radiation Oncology, Stanford University, Stanford, CA
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Stanford University, 875 Blake Wilbur Drive, Stanford, CA 94305, USA. Tel.: +1-650-723-6171; fax: +1-650-725-8231.
    • ,
  • Rob Kirby

      Affiliations

    • Xoft, Inc., Fremont, CA

Received 11 September 2006 ,Revised 3 January 2007 ,Accepted 20 March 2007.

References 

  1. Rivard MJ, Davis SD, DeWerd LA, et al. Calculated and measured brachytherapy dosimetry parameters for the Xoft Axxent™ x-ray source: An electronic brachytherapy source. Med Phys. 2006;33:4020–4032
  2. Rieke J, Rivard M, Axelrod S, et al. Stability of the AXXENT™ X-ray source during irradiation in a Goat Mammary Model for APBI. (Abstr.). American Association of Physicists in Medicine (AAPM) meeting; 2005.
  3. Wazer D, Kaufman S, Cuttino L, et al. Accelerated partial breast radiation: An analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64:489–495
  4. Vicini F, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95:1205–1211
  5. Polgar C, Major T, Fodor J, et al. High dose rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: Seven-year results of a comparative study. Int J Radiat Oncol Biol Phys. 2004;60:1173–1181
  6. King T, Bolton J, Kuske R, et al. Long-term results of wide field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg. 2000;180:299–304
  7. Patel R, Das R. Image-guided breast brachytherapy: An alternative to whole breast radiotherapy. Lancet Oncol. 2006;7:407–415
  8. Perera F, Yu E, Engel J, et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int J Radiat Oncol Biol Phys. 2003;57:1230–1246
  9. Vicini F, Beitsch P, Quiet C, et al. First analysis of patient demographics, technical reproducibility, cosmesis, early toxicity. Results of the American Society of Breast Surgeons Mammosite breast brachytherapy registry trial. Cancer. 2005;104:1138–1148
  10. Keisch M, Vicini F, Scroggins T, et al. Forty-eight month results with the Mammosite brachytherapy applicator: Details regarding cosmesis, toxicity, local control in partial breast irradiation (Abstr.), ASTRO 2005.
  11. Jeruss J, Vicini F, Beitsch P, et al. Initial outcomes for patients treated on the American Society of Breast Surgeons Mammosite clinical trial for ductal carcinoma-in-situ of the breast. Ann Surg Oncol. 2006;13:967–976
  12. Formenti S. External beam partial breast irradiation. Semin Radiat Oncol. 2005;15:92–99
  13. Vicini F, Winter K, Straube W, et al. A Phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: Initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) study 0319. Int J Radiat Oncol Biol Phys. 2005;63:1531–1537
  14. Kozak K, Doppke K, Katz A, et al. Dosimetric comparison of two different three-dimensional conformal external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys. 2006;65:340–346
  15. Intra M, Leonardi C, Luini A, et al. Full dose intraoperative radiotherapy with electrons in breast surgery. Arch Surg. 2005;140:936–939
  16. Vaidya J, Tobias J, Baum M, et al. TARGeted Intraoperative radiotherapy (TARGIT): An innovative approach to partial breast radiation. Semin Radiat Oncol. 2005;15:84–91
  17. Das R, Patel R, Shah H, et al. 3D CT-Based high-dose rate breast brachytherapy implants: Treatment planning and quality assurance. Int J Radiat Oncol Biol Phys. 2004;59:1224–1228
  18. Baglan K, Martinez A, Frazier R, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2001;50:1003–1011
  19. Vicini F, Kestin L, Edmuundson G, et al. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys. 1999;45:803–810
  20. Polgar C, Sulyok S, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:121–128
  21. Perera F, Chisela P, Engel J, et al. Method of localization and implantation of the lumpectomy site for high dose rate brachytherapy after conservative surgery for T1 and T2 breast cancer. Int J Radiat Oncol Biol Phys. 1995;31:959–965
  22. Kestin L, Jaffray D, Edmundson G, et al. Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys. 2000;46:35–43
  23. Chen P, Vicini F, Benitez P, et al. Long term cosmetic results and toxicity after accelerated partial breast irradiation. Cancer. 2006;106:991–999
  24. Esserman L, DaCosta D, d'Almaida M, et al. Imaging findings after breast brachytherapy. AJR Am J Roentgenol. 2006;187:57–64
  25. Shah N, Tenenholz T, Arthur D, et al. Mammosite and interstitial brachytherapy for accelerated partial breast irradiation: Factors that affect toxicity and cosmesis. Cancer. 2004;101:727–734
  26. Kuske R, Winter K, Arthur D, et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2006;65:45–51
  27. Dickler A, Kirk M, Choo J, et al. Treatment volume and dose optimization of Mammosite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2004;59:469–474
  28. Edmundson G, Vicini F, Chen P, et al. Dosimetric characteristics of the Mammosite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2002;52:1132–1139
  29. Evans S, Kaufman S, Price L, et al. Persistent seroma after intraoperative placement of Mammosite for accelerated partial breast irradiation: Incidence, pathologic anatomy, contributing factors. Int J Radiat Oncol Biol Phys. 2006;65:333–339
  30. Major T, Niehoff P, Kovacs G, et al. Dosimetric comparisons between high dose rate interstitial and Mammosite balloon brachytherapy for breast cancer. Radiother Oncol. 2006;79:321–328
  31. Astrahan M, Jozsef G, Streeter O. Optimization of Mammosite therapy. Int J Radiat Oncol Biol Phys. 2004;58:220–232
  32. Vicini F, Chen P, Fraile M, et al. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early stage breast cancer treated with breast-conserving therapy; preliminary results of a pilot trial. Int J Radiat Oncol Biol Phys. 1997;38:301–310
  33. Vicini F, White J, Gustafson G, et al. The use of iodine-125 seeds as a substitute for iridium-192 seeds in temporary interstitial breast implants. Int J Radiat Oncol Biol Phys. 1993;27:561–566
  34. Brenner D, Leu C, Beatty J, et al. Clinical relative biological effectiveness of low energy x-rays emitted by miniature x-ray devices. Phys Med Biol. 1999;44:323–333

 Conflict of interest: Dr. Smitt received consulting fees from Xoft, Inc.

PII: S1538-4721(07)00209-7

doi: 10.1016/j.brachy.2007.03.002

Brachytherapy
Volume 6, Issue 3 , Pages 207-211 , July 2007

Article Tools

* Image Usage & Resolution